-
公开(公告)号:NL2020257B1
公开(公告)日:2019-07-15
申请号:NL2020257
申请日:2018-01-09
Applicant: STICHTING VU
Inventor: GRAEME ALAN KING , FEDERICA BURLA , ERWIN JOHANNES GERARD PETERMAN , GIJS JAN LODEWIJK WUITE
IPC: C12N15/63 , A61K31/711 , C07H21/04 , C12N15/10 , C12Q1/6806
Abstract: A method for supercoiling DNA, e.g. negatively supercoiling DNA, is disclosed. In an initial state, at least part of a DNA molecule is torsionally constrained and associated with a first linking number. The at least part of the DNA molecule has a first end connected to a first body and a second end connected to a second body. The method comprises increasing a distance between the first body and the second body for inducing a torque in the at least part of the DNA molecule and for bringing the at least part of the DNA molecule from the initial state into an intermediate state. In the intermediate state the at least part of the DNA molecule is temporarily torsionally unconstrained for at least partially releasing the induced torque for changing, e.g. decreasing, the first linking number. The method further comprises decreasing the distance between the first and second body for bringing the at least part of the DNA molecule from the intermediate state into a further state in which the at least part of the DNA nmlecule is torsionally constrained and associated with a second linking number different from the first linking number.
-
公开(公告)号:NL2019937B1
公开(公告)日:2019-05-24
申请号:NL2019937
申请日:2017-11-17
Applicant: STICHTING VU
Inventor: GRAEME ALAN KING , ANDREAS SEBASTIAN BIEBRICHER , ERWIN JOHANNES GERARD PETERMAN , IDDO HELLER , GIJS JAN LODEWIJK WUITE
Abstract: One aspect of this disclosure relates to a computer- implemented method for determining a force acting on at least 5 part of a structure, for example a biological structure, such as a DNA molecule. The method comprises controlling a light- sensitive system, e.g. of a microscope, to determine light information based on light from the structure. The light is incident on at least a part of the light sensitive system. The 10 light-sensitive system may be said to capture the light from the structure. The at least part of the structure comprises one or more optically active entities, such as DNA intercalator molecules and donor/acceptor fluorophores. At least one of (i) an optical activity of the entities and (ii) 15 a quantity of the entities depends on the force acting on the at least part of the structure. Furthermore, the light information defines a light property value associated with said at least part of the structure. The method further comprises determining the force acting on the at least part of 20 the structure on the basis of said light property value and a reference light property value.
-
公开(公告)号:NL2021848A
公开(公告)日:2018-11-06
申请号:NL2021848
申请日:2018-10-22
Applicant: STICHTING VU , STICHTING NEDERLANDSE WETENSCHAPPELIJK ONDERZOEK INST , UNIV AMSTERDAM , ASML NETHERLANDS BV
IPC: G03F7/20
Abstract: A metrology apparatus for determining a characteristic of a structure manufactured on a substrate comprising an illumination branch for illuminating the structure with radiation and a detection branch for guiding a portion of the scattered radiation towards a sensor suitable for recording radiation impinging on the sensor, the detection branch comprising an optical element for capturing a portion of the scattered radiation excluding radiation from the specular reflection, the detection branch further comprising a reception unit for receiving reference radiation being coherent with respect to the radiation that illuminates the structure, the detection branch is configured to guide the reference radiation to the sensor for interfering, on the sensor, with the scattered radiation that is captured by the optical element.
-
164.
公开(公告)号:NL2013687B1
公开(公告)日:2016-10-04
申请号:NL2013687
申请日:2014-10-27
Applicant: STICHTING VU-VUMC
Inventor: ERNST JAN BOS
IPC: B29C67/00
Abstract: The present invention provides a method of layered object manufacturing using multiple sheet elements each having a predetermined dimension, wherein the sheet elements comprise first interlocking elements configured to interlock with at least a first further sheet element arranged at a first side of the sheet element, and second interlocking elements configured to interlock with at least a second further sheet element arranged at a second side of the sheet element, wherein the second side is opposite the first side. The method comprises stacking the multiple sheet elements on top of each other, wherein the first interlocking elements of a first one of the multiple sheet elements interlock with the second interlocking elements of a second one of the multiple sheet elements arranged at the first side of the first sheet element, and the second interlocking elements interlock with first interlocking elements of a third one of the multiple sheet elements arranged at the second side of the first sheet element. The invention also provides a sheet element, an object manufacturing device, and object constructed with the method.
-
公开(公告)号:NL2009010C
公开(公告)日:2013-12-17
申请号:NL2009010
申请日:2012-06-15
Applicant: STICHTING VU VUMC
Inventor: KOOL JEROEN , HEUS FERRY ADAM HENRICUS
CPC classification number: G01N30/84 , B01D15/24 , G01N30/30 , G01N30/80 , G01N2030/025 , G01N2030/065 , G01N2030/8435
-
公开(公告)号:SG193539A1
公开(公告)日:2013-10-30
申请号:SG2013070487
申请日:2012-01-16
Applicant: VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG , STICHTING VU VUMC
Inventor: WUERDINGER THOMAS , NILSSON ROLF JONAS
Abstract: The present invention relates to a method of analysing a blood sample of a subject for the presence of a disease marker, said method comprising the steps of a) extracting nucleic acid from anucleated blood cells in said blood sample to provide an anucleated blood cells-extracted nucleic acid fraction, and b) analysing said anucleated blood cells-extracted nucleic acid fraction for the presence of a disease marker, wherein said disease marker is a disease-specific mutation in a gene of a cell of said subject, or wherein said disease marker is a disease-specific expression profile of genes of a cell of said subject.
-
公开(公告)号:NL2008707C2
公开(公告)日:2013-10-29
申请号:NL2008707
申请日:2012-04-26
Applicant: STICHTING VU VUMC
Inventor: BOSCH LINDA JANNA WILLEMIEN , WIT MEIKE , PINTO MORAIS DE CARVALHO BEATRIZ , FIJNEMAN REMONDUS JOHANNES ADRIAAN , MEIJER GERRIT ALBERT , JIMENEZ CORNELIA RAMONA , PIERSMA SANDER ROGIER , PHAM VIET THANG , OUDGENOEG GIDEON
IPC: G01N33/574
-
公开(公告)号:NL2008608C
公开(公告)日:2013-10-09
申请号:NL2008608
申请日:2012-04-05
Applicant: STICHTING VU VUMC
Inventor: ROELOFS THEODORUS FRANK MARIA , STRAALEN NICOLAAS MARIA
IPC: C12Q1/68
-
169.
公开(公告)号:MX2013000606A
公开(公告)日:2013-06-28
申请号:MX2013000606
申请日:2011-07-15
Applicant: STICHTING VU VUMC
Inventor: WUERDINGER THOMAS , NILSSON ROLF JONAS
IPC: G01N33/48
Abstract: La presente invención se relaciona con un método para analizar una muestra de sangre de un sujeto por la presencia de un marcador de enfermedad, dicho método comprende los pasos de a) extraer ácido nucleico de las células de sangre enucleadas en la muestra de sangre, para proporcionar una fracción de ácido nucleico extraída de células de sangre enucleadas, y b) analizar la fracción de ácido nucleico extraída de células de sangre enucleadas por la presencia de un marcador de enfermedad, en donde el marcador de enfermedad es una mutación específica de la enfermedad en un gen de una célula del sujeto, o en donde el marcador de enfermedad es un perfil de expresión específico de enfermedad de genes de una célula del sujeto.
-
公开(公告)号:CA2805586A1
公开(公告)日:2012-01-19
申请号:CA2805586
申请日:2011-07-15
Applicant: STICHTING VU VUMC
Inventor: WURDINGER THOMAS , NILSSON ROLF JONAS
IPC: G01N33/48
Abstract: The present invention relates to a method of analysing a blood sample of a subject for the presence of a disease marker, said method comprising the steps of a) extracting nucleic acid from anucleated blood cells in said blood sample to provide an anucleated blood cells-extracted nucleic acid fraction, and b) analysing said anucleated blood cells-extracted nucleic acid fraction for the presence of a disease marker, wherein said disease marker is a disease-specific mutation in a gene of a cell of said subject, or wherein said disease marker is a disease-specific expression profile of genes of a cell of said subject.
-
-
-
-
-
-
-
-
-